129 related articles for article (PubMed ID: 28765340)
1. Lack of Association for Reported Endocrine Pancreatic Cancer Risk Loci in the PANDoRA Consortium.
Campa D; Obazee O; Pastore M; Panzuto F; Liço V; Greenhalf W; Katzke V; Tavano F; Costello E; Corbo V; Talar-Wojnarowska R; Strobel O; Zambon CF; Neoptolemos JP; Zerboni G; Kaaks R; Key TJ; Lombardo C; Jamroziak K; Gioffreda D; Hackert T; Khaw KT; Landi S; Milanetto AC; Landoni L; Lawlor RT; Bambi F; Pirozzi F; Basso D; Pasquali C; Capurso G; Canzian F
Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1349-1351. PubMed ID: 28765340
[No Abstract] [Full Text] [Related]
2. Genetic polymorphisms of inflammatory response gene TNF-α and its influence on sporadic pancreatic neuroendocrine tumors predisposition risk.
Karakaxas D; Gazouli M; Coker A; Agalianos C; Papanikolaou IS; Patapis P; Liakakos T; Dervenis C
Med Oncol; 2014 Oct; 31(10):241. PubMed ID: 25213764
[TBL] [Abstract][Full Text] [Related]
3. Lack of replication of seven pancreatic cancer susceptibility loci identified in two Asian populations.
Campa D; Rizzato C; Bauer AS; Werner J; Capurso G; Costello E; Talar-Wojnarowska R; Jamroziak K; Pezzilli R; Gazouli M; Khaw KT; Key TJ; Bambi F; Mohelnikova-Duchonova B; Heller A; Landi S; Vodickova L; Theodoropoulos G; Bugert P; Vodicka P; Hoheisel JD; Delle Fave G; Neoptolemos JP; Soucek P; Büchler MW; Giese N; Canzian F
Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):320-3. PubMed ID: 23250936
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 1β gene single-nucleotide polymorphisms and susceptibility to pancreatic neuroendocrine tumors.
Cigrovski Berković M; Catela Ivković T; Marout J; Zjačić-Rotkvić V; Kapitanović S
DNA Cell Biol; 2012 Apr; 31(4):531-6. PubMed ID: 21988351
[TBL] [Abstract][Full Text] [Related]
5. Genetic susceptibility to pancreatic cancer and its functional characterisation: the PANcreatic Disease ReseArch (PANDoRA) consortium.
Campa D; Rizzato C; Capurso G; Giese N; Funel N; Greenhalf W; Soucek P; Gazouli M; Pezzilli R; Pasquali C; Talar-Wojnarowska R; Cantore M; Andriulli A; Scarpa A; Jamroziak K; Delle Fave G; Costello E; Khaw KT; Heller A; Key TJ; Theodoropoulos G; Malecka-Panas E; Mambrini A; Bambi F; Landi S; Pedrazzoli S; Bassi C; Pacetti P; Piepoli A; Tavano F; di Sebastiano P; Vodickova L; Basso D; Plebani M; Fogar P; Büchler MW; Bugert P; Vodicka P; Boggi U; Neoptolemos JP; Werner J; Canzian F
Dig Liver Dis; 2013 Feb; 45(2):95-9. PubMed ID: 23206934
[TBL] [Abstract][Full Text] [Related]
6. ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium.
Rizzato C; Campa D; Pezzilli R; Soucek P; Greenhalf W; Capurso G; Talar-Wojnarowska R; Heller A; Jamroziak K; Khaw KT; Key TJ; Bambi F; Landi S; Mohelnikova-Duchonova B; Vodickova L; Büchler MW; Bugert P; Vodicka P; Neoptolemos JP; Werner J; Hoheisel JD; Bauer AS; Giese N; Canzian F
Oncol Rep; 2013 Apr; 29(4):1637-44. PubMed ID: 23403949
[TBL] [Abstract][Full Text] [Related]
7. Do pancreatic cancer and chronic pancreatitis share the same genetic risk factors? A PANcreatic Disease ReseArch (PANDoRA) consortium investigation.
Campa D; Pastore M; Capurso G; Hackert T; Di Leo M; Izbicki JR; Khaw KT; Gioffreda D; Kupcinskas J; Pasquali C; Macinga P; Kaaks R; Stigliano S; Peeters PH; Key TJ; Talar-Wojnarowska R; Vodicka P; Valente R; Vashist YK; Salvia R; Papaconstantinou I; Shimizu Y; Valsuani C; Zambon CF; Gazouli M; Valantiene I; Niesen W; Mohelnikova-Duchonova B; Hara K; Soucek P; Malecka-Panas E; Bueno-de-Mesquita HBA; Johnson T; Brenner H; Tavano F; Fogar P; Ito H; Sperti C; Butterbach K; Latiano A; Andriulli A; Cavestro GM; Busch ORC; Dijk F; Greenhalf W; Matsuo K; Lombardo C; Strobel O; König AK; Cuk K; Strothmann H; Katzke V; Cantore M; Mambrini A; Oliverius M; Pezzilli R; Landi S; Canzian F
Int J Cancer; 2018 Jan; 142(2):290-296. PubMed ID: 28913878
[TBL] [Abstract][Full Text] [Related]
8. Analysis of polymorphisms in EGF, EGFR and HER2 genes in pancreatic neuroendocrine tumors (PNETs).
Marinović S; Cigrovski Berković M; Zjačić-Rotkvić V; Kapitanović S
Cancer Genet; 2022 Aug; 266-267():44-50. PubMed ID: 35777127
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study identifies an early onset pancreatic cancer risk locus.
Campa D; Gentiluomo M; Obazee O; Ballerini A; Vodickova L; Hegyi P; Soucek P; Brenner H; Milanetto AC; Landi S; Gao X; Bozzato D; Capurso G; Tavano F; Vashist Y; Hackert T; Bambi F; Bursi S; Oliverius M; Gioffreda D; Schöttker B; Ivanauskas A; Mohelnikova-Duchonova B; Darvasi E; Pezzilli R; Małecka-Panas E; Strobel O; Gazouli M; Katzke V; Szentesi A; Cavestro GM; Farkas G; Izbicki JR; Moz S; Archibugi L; Hlavac V; Vincze Á; Talar-Wojnarowska R; Rusev B; Kupcinskas J; Greenhalf B; Dijk F; Giese N; Boggi U; Andriulli A; Busch OR; Vanella G; Vodicka P; Nentwich M; Lawlor RT; Theodoropoulos GE; Jamroziak K; Zuppardo RA; Moletta L; Ginocchi L; Kaaks R; Neoptolemos JP; Lucchesi M; Canzian F
Int J Cancer; 2020 Oct; 147(8):2065-2074. PubMed ID: 32270874
[TBL] [Abstract][Full Text] [Related]
10. Genetic Susceptibility in Understanding of Pancreatic Ductal Adenocarcinoma Risk: A Decade-Long Effort of the PANDORA Consortium.
Vodickova L; Horak J; Vodicka P
Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):942-948. PubMed ID: 35506247
[TBL] [Abstract][Full Text] [Related]
11. Common germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumors.
Campa D; Capurso G; Pastore M; Talar-Wojnarowska R; Milanetto AC; Landoni L; Maiello E; Lawlor RT; Malecka-Panas E; Funel N; Gazouli M; De Bonis A; Klüter H; Rinzivillo M; Delle Fave G; Hackert T; Landi S; Bugert P; Bambi F; Archibugi L; Scarpa A; Katzke V; Dervenis C; Liço V; Furlanello S; Strobel O; Tavano F; Basso D; Kaaks R; Pasquali C; Gentiluomo M; Rizzato C; Canzian F
Sci Rep; 2016 Dec; 6():39565. PubMed ID: 28008994
[TBL] [Abstract][Full Text] [Related]
12. Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms.
Obazee O; Capurso G; Tavano F; Archibugi L; De Bonis A; Greenhalf W; Key T; Pasquali C; Milanetto AC; Hackert T; Fogar P; Liço V; Dervenis C; Lawlor RT; Landoni L; Gazouli M; Zambon CF; Funel N; Strobel O; Jamroziak K; Cantù C; Malecka-Panas E; Landi S; Neoptolemos JP; Basso D; Talar-Wojnarowska R; Rinzivillo M; Andriulli A; Canzian F; Campa D
Carcinogenesis; 2018 Mar; 39(3):360-367. PubMed ID: 29309705
[TBL] [Abstract][Full Text] [Related]
13. The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer.
Campa D; Gentiluomo M; Stein A; Aoki MN; Oliverius M; Vodičková L; Jamroziak K; Theodoropoulos G; Pasquali C; Greenhalf W; Arcidiacono PG; Uzunoglu F; Pezzilli R; Luchini C; Puzzono M; Loos M; Giaccherini M; Katzke V; Mambrini A; Kiudeliene E; Federico KE; Johansen J; Hussein T; Mohelnikova-Duchonova B; van Eijck CHJ; Brenner H; Farinella R; Pérez JS; Lovecek M; Büchler MW; Hlavac V; Izbicki JR; Hackert T; Chammas R; Zerbi A; Lawlor R; Felici A; Götz M; Capurso G; Ginocchi L; Gazouli M; Kupcinskas J; Cavestro GM; Vodicka P; Moz S; Neoptolemos JP; Kunovsky L; Bojesen SE; Carrara S; Gioffreda D; Morkunas E; Abian O; Bunduc S; Basso D; Boggi U; Wlodarczyk B; Szentesi A; Vanella G; Chen I; Bijlsma MF; Kiudelis V; Landi S; Schöttker B; Corradi C; Giese N; Kaaks R; Peduzzi G; Hegyi P; Morelli L; Furbetta N; Soucek P; Latiano A; Talar-Wojnarowska R; Lindgaard SC; Dijk F; Milanetto AC; Tavano F; Cervena K; Erőss B; Testoni SG; Verhagen-Oldenampsen JHE; Małecka-Wojciesko E; Costello E; Salvia R; Maiello E; Ermini S; Sperti C; Holleczek B; Perri F; Skieceviciene J; Archibugi L; Lucchesi M; Rizzato C; Canzian F
Crit Rev Oncol Hematol; 2023 Jun; 186():104020. PubMed ID: 37164172
[TBL] [Abstract][Full Text] [Related]
14. Distinct Prognostic Factors in Sporadic and Multiple Endocrine Neoplasia Type 1-Related Pancreatic Neuroendocrine Tumors.
Kfir SK; Halperin R; Percik R; Uri I; Halpern N; Shlomai G; Laish I; Tirosh A; Tirosh A
Horm Metab Res; 2021 May; 53(5):319-325. PubMed ID: 33878789
[TBL] [Abstract][Full Text] [Related]
15. Utility of chromogranin A, pancreatic polypeptide, glucagon and gastrin in the diagnosis and follow-up of pancreatic neuroendocrine tumours in multiple endocrine neoplasia type 1 patients.
Qiu W; Christakis I; Silva A; Bassett RL; Cao L; Meng QH; Gardner Grubbs E; Zhao H; Yao JC; Lee JE; Perrier ND
Clin Endocrinol (Oxf); 2016 Sep; 85(3):400-7. PubMed ID: 27256431
[TBL] [Abstract][Full Text] [Related]
16. Endoscopic Ultrasound Features of Multiple Endocrine Neoplasia Type 1-Related versus Sporadic Pancreatic Neuroendocrine Tumors: A Single-Center Retrospective Study.
Tamagno G; Scherer V; Caimo A; Bergmann SR; Kann PH
Digestion; 2018; 98(2):112-118. PubMed ID: 29698969
[TBL] [Abstract][Full Text] [Related]
17. Molecular alterations in sporadic pancreatic neuroendocrine microadenomas.
Hadano A; Hirabayashi K; Yamada M; Kawanishi A; Takanashi Y; Kawaguchi Y; Nakagohri T; Nakamura N; Mine T
Pancreatology; 2016; 16(3):411-5. PubMed ID: 26905832
[TBL] [Abstract][Full Text] [Related]
18. Association of Pancreatic Cancer Susceptibility Variants with Risk of Breast Cancer in Women of European and African Ancestry.
Wang S; Zheng Y; Ogundiran TO; Ojengbede O; Zheng W; Nathanson KL; Nemesure B; Ambs S; Olopade OI; Huo D
Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):116-118. PubMed ID: 29254938
[No Abstract] [Full Text] [Related]
19. Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study.
Childs EJ; Chaffee KG; Gallinger S; Syngal S; Schwartz AG; Cote ML; Bondy ML; Hruban RH; Chanock SJ; Hoover RN; Fuchs CS; Rider DN; Amundadottir LT; Stolzenberg-Solomon R; Wolpin BM; Risch HA; Goggins MG; Petersen GM; Klein AP
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1185-91. PubMed ID: 27197284
[TBL] [Abstract][Full Text] [Related]
20. A Direct Comparison of Patients With Hereditary and Sporadic Pancreatic Neuroendocrine Tumors: Evaluation of Clinical Course, Prognostic Factors and Genotype-Phenotype Correlations.
Soczomski P; Jurecka-Lubieniecka B; Krzywon A; Cortez AJ; Zgliczynski S; Rogozik N; Oczko-Wojciechowska M; Pawlaczek A; Bednarczuk T; Jarzab B
Front Endocrinol (Lausanne); 2021; 12():681013. PubMed ID: 34122352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
